Therefore, a defective function of the PD-1/PD-L1 interaction in antigen presentation and/or effector T-cell functions arise as relevant for the immune checkpoint inhibitory response in cHL, including the involvement of the secreted forms of PD-1 and PD-L1 [7,52]. The gene discussed is PDCD1; the disease is classic Hodgkin lymphoma.